Stock Markets April 28, 2026 08:29 PM

Pershing Square Secures $5 Billion for New U.S. Closed-End Fund

Ackman launches a flagship NY-listed vehicle without performance fees, set to trade alongside Pershing Square on the NYSE

By Priya Menon
Pershing Square Secures $5 Billion for New U.S. Closed-End Fund

Pershing Square has raised $5 billion for a newly launched closed-end fund that will be part of a combined U.S. initial public offering for the alternative asset manager. The fund, Pershing Square USA (PSUS), is the firm's first product marketed to both institutional and retail U.S. investors that carries no performance fees. Both PSUS and Pershing Square (PS) are scheduled to begin trading on the New York Stock Exchange following the offering.

Key Points

  • Pershing Square raised $5 billion for a new closed-end fund that is part of a combined U.S. IPO of the asset manager.
  • The new fund, Pershing Square USA (PSUS), is the firm's first product offered without performance fees and is marketed to both U.S. institutional and retail investors.
  • Pershing Square USA (PSUS) and Pershing Square (PS) will begin trading on the New York Stock Exchange under the symbols "PSUS" and "PS," respectively, with reported oversubscription and heavy institutional participation.

April 28 - Bill Ackman’s Pershing Square announced it has raised $5 billion for a new closed-end fund that forms part of a combined U.S. initial public offering for the alternative asset manager. The firm said the capital raise accompanies an IPO that will bring a flagship Pershing Square fund to a New York listing.

The newly created vehicle is Pershing Square’s first fund offered without performance fees and is being marketed to both U.S. institutional and retail investors. The offering represents a notable step in the firm’s efforts to establish a flagship, publicly traded product in New York.

Pershing Square had attempted to list the new fund, Pershing Square USA (PSUS), earlier in 2024 but withdrew that IPO days before its intended New York debut after demand came in lower than anticipated. The firm subsequently relaunched the offering as part of the combined IPO.

Pershing Square USA and Pershing Square are slated to begin trading on the New York Stock Exchange under the symbols "PSUS" and "PS," respectively, on Wednesday.

Sources of demand for the offering included family offices, pension funds, insurance companies, and high-net-worth investors, who lined up to participate roughly 22 years after Ackman founded his hedge fund, Pershing Square Capital Management, in New York.

Reports issued prior to the offering indicated the IPO was oversubscribed, with more than 85% of orders coming from institutional investors, underscoring the heavy institutional interest in the deal.


Context and implications

The launch of this closed-end fund without performance fees marks a structural change for Pershing Square’s product mix, and the dual listing of PSUS and PS on the NYSE will put both symbols into the public trading ecosystem simultaneously. The oversubscription and the concentration of institutional orders were prominent features of the order book as the offering moved forward.

What remains limited in the public account

The firm disclosed the total amount raised for the closed-end vehicle and the planned trading symbols, and reporting around order composition highlighted institutional dominance in demand. Additional details beyond those public statements and the historical note about the previously withdrawn 2024 attempt were not disclosed in the announcements accompanying the offering.

Risks

  • Demand uncertainty: Pershing Square previously withdrew an IPO for the same fund in 2024 after demand proved lower than expected, indicating prior volatility in investor appetite.
  • Order composition uncertainty: Reports indicated the IPO was oversubscribed with more than 85% of orders coming from institutional investors, reflecting concentration in the investor base and potential limitations on retail participation.

More from Stock Markets

Australian Shares Slip as Healthcare, Financials and Gold Weigh on Index Apr 29, 2026 Fuchs posts Q1 results above forecasts, raises sales outlook for 2026 Apr 29, 2026 Huhtamaki Tops Q1 Expectations but Flags Rising Polymer Costs as Margin Risk Apr 29, 2026 Kambi Holds FY26 EBITA Target Despite €4m Colombia Tax Hit Apr 29, 2026 Pernod Ricard Calls Off Merger Negotiations With Brown-Forman Apr 29, 2026